C. Mannhalter

L. Endler, O. Wagner, R. Prager, 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis

A. Kaider, P. Kyrle, C. Mannhalter, 2005, Journal of thrombosis and haemostasis : JTH.

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

H. Döhner, U. Jäger, A. Chott, 2005, Leukemia.

Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms.

A. Chott, C. Mannhalter, M. Födinger, 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.

O. Haas, D. Niederwieser, H. Greinix, 1997, Blood.

Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

O. Haas, O. Haas, C. Fonatsch, 1998, Bone Marrow Transplantation.

Spectrum of causative mutations in patients with haemophilia A in Austria

C. Male, W. Muntean, S. Reitter, 2010, Thrombosis and Haemostasis.

Blood Coagulation , Fibrinolysis and Cellular Haemostasis Spectrum of causative mutations in patients with haemophilia A in Austria

C. Mannhalter, C. Male, I. Pabinger, 2018 .

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

S. Eichinger, P. Kyrle, H. Haslacher, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

G. Ott, U. Jaeger, A. Chott, 2004, Leukemia.

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

M. Schemper, P. Neumeister, C. Mannhalter, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Evidence of a U‐shaped association between factor XII activity and overall survival

B. Jilma, C. Mannhalter, P. Quehenberger, 2007, Journal of thrombosis and haemostasis : JTH.

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response

R. Greil, U. Jäger, M. Putman, 2012, Haematologica.

Plasminogen Deficiency: An Additional Risk Factor for Thrombosis in a Family with Factor V R506Q Mutation?

B. Lämmle, M. Furlan, F. Demarmels Biasiutti, 1996, Thrombosis and Haemostasis.

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

G. Heinze, K. Laczika, O. Haas, 1997, Leukemia.

Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.

A. Chott, C. Mannhalter, I. Mosberger, 1998, The American journal of pathology.

The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

E. Minar, S. Eichinger, P. Kyrle, 1997, Thrombosis and Haemostasis.

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

L. Deecke, W. Serles, C. Mannhalter, 1999, Thrombosis research.

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

F. Rosendaal, C. Mannhalter, I. Pabinger, 2004, Journal of thrombosis and haemostasis : JTH.

Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy

C. Baumgartner, F. Zimprich, E. Stogmann, 2004, Neurology.

Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation.

D. Niederwieser, H. Greinix, C. Mannhalter, 2000, Transplantation.

Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden.

P. Kyrle, C. Mannhalter, P. Knöbl, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

4G4G genotype of the plasminogen activator inhibitor‐1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

C. Mannhalter, W. Zenz, G. Endler, 2007, Journal of thrombosis and haemostasis : JTH.

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.

W. Hörl, C. Mannhalter, G. Sunder-Plassmann, 1998, Kidney international.

No impact of endogenous prothrombotic conditions on the risk of central venous line‐related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis)

E. Mlczoch, C. Mannhalter, C. Male, 2014, Journal of thrombosis and haemostasis : JTH.

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.

R. Brezinschek, P. Neumeister, C. Mannhalter, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk

B. Boehm, B. Winkelmann, W. Maerz, 2008, Journal of thrombosis and haemostasis : JTH.

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene.

S. Béguin, S. Eichinger, P. Kyrle, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.

U. Jaeger, D. Niederwieser, P. Kyrle, 1997, Blood.

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

T. Lion, C. Bock, P. Valent, 2016, Leukemia.

Platelet‐borne complement proteins and their role in platelet–bacteria interactions

C. Mannhalter, Itziar Arbesú, I. Arbesu, 2016, Journal of thrombosis and haemostasis : JTH.

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)

Eva-Maria Reitter, J. Thaler, C. Mannhalter, 2015, Journal of thrombosis and haemostasis : JTH.

Protein S Deficiency: A Database of Mutations

P. Reitsma, D. Cooper, F. Bernardi, 1997, Thrombosis and Haemostasis.

Identification of Mutations in the Canine von Willebrand Factor Gene Associated with Type III von Willebrand Disease

J. V. van Mourik, F. Dorner, C. Mannhalter, 1998, Thrombosis and Haemostasis.

Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.

L. Deecke, W. Serles, P. Schnider, 1999, The Journal of laboratory and clinical medicine.

No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.

S. Eichinger, P. Kyrle, C. Mannhalter, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

W. Hörl, C. Mannhalter, I. Pabinger, 1997, Kidney international.

Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia

P. Valent, A. Schmitt-Graeff, M. Mayerhofer, 2013, Allergy.